Snowball logo
logo
CYT

Cyteir Therapeutics, Inc. Common Stock

CYT NYSE Не торгуется
-- $0,00 $  (0%)
Оценка
EPS
-0,93
Рост
Чистый доход, YoY
65,81%
FCF, YoY
63,78%
Другое
Размер лота
1 шт.
О компании
Тикер
CYT
ISIN
US23284P1030
Страна
США
Сектор (GICS)
Здравоохранение
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. Cyteir Therapeutics, Inc. was incorporated in 2012 and is headquartered in Lexington, Massachusetts.

Часто задаваемые вопросы

В каком секторе работает Cyteir Therapeutics, Inc. Common Stock (CYT)?

Cyteir Therapeutics, Inc. Common Stock относится к сектору Здравоохранение.

Выплачивает ли Cyteir Therapeutics, Inc. Common Stock (CYT) дивиденды?

Нет, Cyteir Therapeutics, Inc. Common Stock не выплачивает дивиденды.